CX Institutional’s PRA Health Sciences, Inc. PRAH Stock Holding History

CX Institutional’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-68	Closed	-$11K	–	990
2021 Q2	$11K	Hold	68	–	–	﹤0.01%	830
2021 Q1	$10K	Hold	68	–	–	﹤0.01%	768
2020 Q4	$9K	Hold	68	–	–	﹤0.01%	744
2020 Q3	$7K	Hold	68	–	–	﹤0.01%	720
2020 Q2	$7K	Hold	68	–	–	﹤0.01%	633
2020 Q1	$6K	Hold	68	–	–	﹤0.01%	536
2019 Q4	$8K	Hold	68	–	–	﹤0.01%	480
2019 Q3	$7K	Buy	68 +51	+300%	+$5.07K	﹤0.01%	528
2019 Q2	$2K	Buy	+17	New	+$1.62K	﹤0.01%	801

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

CX Institutional's PRAH Position: Q3 2021 in Review

CX Institutional sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 68 shares — an estimated $11K sold.

CX Institutional first reported a position in PRAH in Q2 2019 and held it in 9 quarters. The position peaked at $11K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

CX Institutional reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
CX Institutional sold 68 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $11K.
CX Institutional first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 9 quarters.
CX Institutional's PRA Health Sciences, Inc. position peaked at $11K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on CX Institutional's 13F filing for Q3 2021, filed 10 Nov 2021.